Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2018 Earnings Presentation
17 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Jul 26, 2018
Slide 1: Conference call Interim report January 1 to June 30, 2018
Conference call Interim report January 1 to June 30, 2018 Lübeck, July 26, 2018
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights H1
Business Highlights H1 CC order intake continued to be Net Sales positive. Orders on hand remain above prior year’s level. +10.1% +4.0% Currency Currency Order intake (currency adjusted): adjusted adjusted 1,116 1,116 Q2 +1.4% yoy H1 +2.0% yoy 620 581 Strong catch up of net sales on the back o
Slide 4: Order development in H1
Order development in H1 Order entry (€ million) Net Sales Group Medical Safety Group America 228 -2.2% -5.8% +6.3% -2.1% Africa, Asia, +7.1% +3.9% +5.2% 339 +6.2% Australia Europe 707 +1.5% +0.8% +2.6% +5.8% Group 1,274 +2.0% +1.2% +3.5% +4.0% Growth rates are net of currency effects 4
Slide 5: Business development H1
Business development H1 Q2 2017 Q2 2018 Change 6M 2017 6M 2018 Change € million € million % € million € million % Order Intake 662.7 652.3 -1.6 1,302.0 1,273.8 -2.2 % growth (FX adjusted) 7.0% 1.4% 6.2% 2.0% Net Sales 581.0 620.2 6.7 1,116.0 1,115.8 0.0 % growth (FX adjusted) 1.0% 10.1% 0.0% 4.0% Gr
Slide 6: Functional Expenses H1
Functional Expenses H1 6M 2017 6M 2018 Change Change net of FX € million € million % % R&D -111.9 -127.9 14.3 16.9 % of Net Sales -10.0% -11.5% Sales & Marketing -272.0 -284.6 4.6 8.5 % of Net Sales -24.4% -25.5% Administration -91.1 -99.9 9.6 12.6 % of Net Sales -8.2% -9.0% SG&A -363.1 -384.5 5.9 9
Slide 7: Key Figures H1
Key Figures H1 6M 2017 6M 2018 Change € million € million % Cashflow from operating activities 31.2 -66.7 >-100 Investments 42.1 34.8 -17.3 1 Cash and cash equivalents 175.7 139.4 -20.7 1 Net financial debt 41.8 78.8 88.8 1 2 0.18 0.42 Net financial debt /EBITDA 1 Capital employed 1,229.9 1,299.0 5.
Slide 8: Outlook
Outlook EXPECTATIONS FOR FISCAL YEAR 2018 2017 2018e Current forecast 3.3% +2.0 - +5.0 % Net sales Confirmed (net of currency effects) (net of currency effects) EBIT margin 6.1% 4.0 - 6.0%* Confirmed* * based on exchange rates at the start of the year 2018; Due to the earnings performance in the fir
Slide 9: Questions & Answers
Questions & Answers Drager 9 Drager. Technik fiir das Leben®
Slide 10: Guidance 2018
Guidance 2018 2017 2018e 3.3% +2.0 - +5.0 % Net sales (net of currency effects) (net of currency effects) EBIT margin 6.1% 4.0 - 6.0%* Dräger Value Added EUR 70.7 million EUR 15 - 65 million* Other forecast figures: Gross margin 44.8 % 44.0 - 46.0 %* Research and development co EUR 234.7 million EUR
Slide 11: Business development Q2 Segments
Business development Q2 Segments Europe Americas Africa, Asia, Australia Dräger Group Q2 2017 Q2 2018 Q2 2017 Q2 2018 Q2 2017 Q2 2018 Q2 2017 Q2 2018 € million € million € million € million € million € million € million € million Order entry 359.2 365.1 134.4 117.5 169.1 169.7 662.7 652.3 Net Sales
Slide 12: Business development H1 Segments
Business development H1 Segments Europe Americas Africa, Asia, Australia Dräger Group 6M 2017 6M 2018 6M 2017 6M 2018 6M 2017 6M 2018 6M 2017 6M 2018 € million € million € million € million € million € million € million € million Order entry 706.8 706.6 259.1 228.0 336.2 339.1 1,302.0 1,273.8 Net Sa
Slide 13: Business development Medical
Business development Medical Q2 2017 Q2 2018 Change Change 6M 2017 6M 2018 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 435.7 413.6 -5.1 -2.3 841.0 815.1 -3.1 1.2 Europe 216.8 216.1 -0.3 1.1 414.7 412.5 -0.5 0.8 America 97.7 78.8 -19.3 -12.7 181.4 153
Slide 14: Business development Safety
Business development Safety Q2 2017 Q2 2018 Change Change 6M 2017 6M 2018 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 226.9 238.7 5.2 8.5 461.1 458.7 -0.5 3.5 Europe 142.4 149.0 4.7 6.6 292.0 294.1 0.7 2.6 America 36.7 38.7 5.5 12.8 77.7 74.5 -4.0 6.
Slide 15: Cash-flow statement
Cash-flow statement 6M 2017 6M 2018 Change € million € million % Group net profit 8.2 -29.3 >-100 Change in inventories -59.0 -86.1 -46.0 Change in receivables 133.8 82.1 -38.6 Change in payables -23.7 -28.3 -19.3 Depreciation and amortization 41.0 42.5 3.5 Other operating cash flow items -69.2 -47.
Slide 16: Financial calendar 2018
Financial calendar 2018 March 8, 2018 - Analysts’ meeting April 26, 2018 - Report for the first three months 2018 Conference call May 4, 2018 - Annual shareholders' meeting, Lübeck, Germany July 26, 2018 - Report for the first six months 2018 Conference call October 30, 2018 - Report for the first n
Slide 17: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Drägerwerk AG & Co. KGaA — H1 2018 Earnings Presentation on 6ix